Sep 11, 2026 07:00AM
Aug 14, 2026 04:33AM
Aug 5, 2026 04:08PM
Jul 22, 2026 03:23AM
Jul 1, 2026 04:52AM
Jun 15, 2026 05:15AM
Jun 12, 2026 12:45PM Lyell Immunopharma reports safety data for lymphoma CAR T-cell therapy
Jun 9, 2026 06:47AM
Jun 9, 2026 04:58AM
Jun 3, 2026 06:55AM
May 1, 2026 07:57AM
May 1, 2026 05:29AM
Apr 10, 2026 05:54AM
Mar 23, 2026 06:48AM H.C. Wainwright Reiterates Buy Rating on Lyell Immunopharma (LYEL)
Mar 16, 2026 05:02AM
Mar 9, 2026 03:28AM
Dec 22, 2025 12:05PM
Dec 9, 2025 06:16AM
Dec 8, 2025 02:52AM
Dec 5, 2025 04:39PM
Nov 10, 2025 07:30AM Lyell Immunopharma acquires CAR T-cell therapy for colorectal cancer
Sep 26, 2025 07:17AM
Sep 16, 2025 04:24PM
Aug 12, 2025 04:52PM
Jul 25, 2025 08:01AM
Jun 24, 2025 06:48AM
Jun 17, 2025 06:31AM
Apr 15, 2025 09:00AM Lyell Immunopharma (LYEL) Receives RMAT Designation for LYL314 for the Treatment of Relapsed and/or Refractory Large B-Cell Lymphoma
Mar 13, 2025 06:47AM
Nov 7, 2024 04:19PM
Oct 31, 2024 04:00PM
Oct 30, 2024 06:18AM
Oct 28, 2024 07:30AM
Oct 24, 2024 04:00PM
Jun 26, 2024 07:02AM Lyell Immunopharma (LYEL) Reports Dose-dependent Clinical Activity from Phase 1 Trial of LYL797

466,307 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All